4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-22-005451
Options or other derivatives
- CHIEF COMMERCIAL OFFICER acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · CHIEF COMMERCIAL OFFICER
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +85,000 | 85,000 | D |
Loading xslF345X03/tm223835-2_4seq1.xml…